Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Shire
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Aged at least 18 years with chronic kidney disease (Kidney Disease Outcomes Quality Initiative \[KDOQI\] stage III-V).
Stable on and taking doses \<= 10,000 IU/week of subcutaneous (sc) EPO or requiring initiation of EPO.
Transferrin saturation \>= 20% and ferritin \>= 100 ng/mL.
You may not be if
Uncontrolled hypertension.
Requiring doses of EPO \> 10,000 IU/week.
Two or more doses of prescribed EPO treatment missed ot withheld by physician order in the 14 days immediately prior tp randomisation in the study.
Active bleeding disorder (diathesis) (for example, Gastrointestinal or Genitourinary tract bleeding).
Treatment with immunosuppressive drugs (other than corticosteroids for a chronic condition) in the 30 days immediately prior to randomisation in the study.
Androgen therapy in the 30 days immediately prior to randomisation in the study.
Known Human Immunodeficiency Virus(HIV)infection.
History of hypersensitivity to EPO therapy or to any of the excipients of Dynepo.
